Stay updated on Pembrolizumab SubQ vs IV in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a new page revision deployed on the site, with no impact on the actual study data or the information presented about the trial.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history now lists Revision: v3.6.5 and no longer shows Revision: v3.6.4, reflecting a new build of the site’s history UI. This change documents the latest platform update without altering study information.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now shows Revision: v3.6.4 in the footer, replacing Revision: v3.6.3, indicating a platform/UI update.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a small behind-the-scenes platform version update. This change does not alter study data or visible features.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.6.2 appears in the page history, replacing the previous Revision: v3.6.0. This reflects a minor update to the revision metadata of the record and does not change study data or public content.SummaryDifference0.1%

- Check92 days agoChange DetectedA new revision v3.6.0 adds a note that the study is no longer looking for participants, and the previous revision v3.5.5 is removed from the history.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab SubQ vs IV in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.